International Flavors & Fragrances Inc. (IFF) is a focal point for investors analyzing potential risk given some ongoing fluctuations in its stock price. The company’s stock has been considered a ‘hold’ at best due to such volatility. Significant transactions in the company’s shares have been reported, with notable purchases by Pacer Advisors Inc. and Robeco Institutional Asset Management B.V. and major sales by Smith Group Asset Management LLC, Reports on IFF's Q3 2024 earnings highlighted both strengths and areas for development, with a particular focus on its robust sales. The IFF management team is due to present the Q4 2024 and full-year 2024 results in February 2025. Notably, IFF has appointed Michael DeVeau as its new Chief Financial Officer. Investment developments and the company's financial performance are captured in various price targets set by companies such as Barclays. A major recent development for IFF has been the sale of its pharmaceutical unit to France's Roquette in a deal valued at $2.85 billion. The company continues its expansive endeavors with plans to open a new innovation center in Shanghai and the unveiling of an AI-Powered Chinese Fragrance Program. In addition to this, IFF has recently announced significant changes in its board ahead of the 2025 shareholders meeting.
International Flavors Fragrances IFF News Analytics from Tue, 19 Mar 2024 07:00:00 GMT to Sat, 01 Feb 2025 15:22:00 GMT -
Rating 1
- Innovation 2
- Information 8
- Rumor -6
